Although uncertainty remains regarding long-term hearing outcomes, CI offers significantly better results than ABI.450, 467, 471 Neither the primary treatment modality nor the cause of the tumor (NF2-related or sporadic) appears to have a significant effect on outcome. Here, NF2 is linked to neoplasm.